Influx Healthtech IPO subscribed over 41 times on Day 3; GMP signals strong listing

Influx Healthtech's IPO witnessed an overwhelming response, being oversubscribed 41.07 times, driven by strong retail and NII participation. The IPO, priced at Rs 91-96, saw grey market premiums suggesting a 39% listing gain. The company plans to use the raised funds to establish new manufacturing facilities for nutraceutical and veterinary products.